This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

William I. Wei, MS, DLO, FRCSE, FACS; Chiu M. Ho, FRCSE, FRACS; Po W. Yuen, DLO, FRCSE; Ching F. Fung, FRCSE; Jonathan S. T. Sham, DMRT, FRCR; Kam H. Lam, MS, FRCSE, FRACS

Arch Otolaryngol Head Neck Surg. 1995;121(6):638-642.

Abstract
T efficacy of the anterolateral approach to the nasopharynx and its vicinity was evaluated. Using this maxillary swing approach, we have removed tumors in and around the nasopharyngeal region in 26 patients. Among them, 18 suffered from recurrent primary nasopharyngeal carcinoma after external radiotherapy, three patients had chordoma, two had schwannoma, one had adenocarcinoma of the nasopharynx, and one had malignant fibrous histiocytoma. The last patient had a recurrent deep-lobe parotid gland tumor localized in the paranasopharyngeal space. The facial wounds in all 26 patients healed primarily with no evidence of necrosis of the maxilla. Seven patients developed palatal fistula, five of them subsequently healed, whereas one patient required surgical closure and one had to wear a dental plate. This group of patients was followed up from 4 to 42 months (median, 15 months). Among the 18 patients with recurrent nasopharyngeal carcinoma, five had local recurrence, four died of other conditions, and nine of them are still alive with no evidence of disease. This gives an actuarial control of tumor in the nasopharynx of 42% at 3.5 years. In the eight patients remaining, one died of recurrent chordoma, two are alive with recurrent disease, and five are free of disease. Exposure of the nasopharynx and the paranasopharyngeal space is possible using the anterolateral approach. The associated morbidity is low. (Arch Otolaryngol Head Neck Surg. 1995;121:638-642)

Author Affiliations
From the Departments of Surgery (Drs Wei, Ho, Yuen, Fung, and Lam) and Radiation Oncology (Dr Sham), The University of Hong Kong, Queen Mary Hospital.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Chemoradiotherapy for Locally Recurrent Nasopharyngeal Carcinoma: Treatment Outcome and Prognostic Factors
Nakamura et al.
Jpn J Clin Oncol 2008;38:803-809.
ABSTRACT | FULL TEXT  

Nasopharyngectomy and Surgical Margin Status: A Survival Analysis
Vlantis et al.
Arch Otolaryngol Head Neck Surg 2007;133:1296-1301.
ABSTRACT | FULL TEXT  

Quality of life of patients with recurrent nasopharyngeal carcinoma treated with nasopharyngectomy using the maxillary swing approach.
Ng and Wei
Arch Otolaryngol Head Neck Surg 2006;132:309-316.
ABSTRACT | FULL TEXT  

Curative Surgery for Recurrent Nasopharyngeal Carcinoma via the Infratemporal Fossa Approach
Choi and Lee
Arch Otolaryngol Head Neck Surg 2005;131:213-216.
ABSTRACT | FULL TEXT  

Quantitative Plasma Hypermethylated DNA Markers of Undifferentiated Nasopharyngeal Carcinoma
Wong et al.
Clin. Cancer Res. 2004;10:2401-2406.
ABSTRACT | FULL TEXT  

Prognostic Factors and Outcome for Nasopharyngeal Carcinoma
Farias et al.
Arch Otolaryngol Head Neck Surg 2003;129:794-799.
ABSTRACT | FULL TEXT  

Salvage Surgery for Recurrent Nasopharyngeal Carcinoma
Hao et al.
Arch Otolaryngol Head Neck Surg 2002;128:63-67.
ABSTRACT | FULL TEXT  

Factors Affecting the Overall Survival After Salvage Surgery in Patients With Recurrent Nasopharyngeal Carcinoma at the Primary Site: Experience With 60 Cases
Hsu et al.
Arch Otolaryngol Head Neck Surg 2001;127:798-802.
ABSTRACT | FULL TEXT